Bladder Cancer Videos
Latest Bladder Cancer News
Adjuvant chemotherapy is associated with better survival among patients with advanced nonmetastatic bladder cancer.
It has implications for treatment decisions and prognosis.
In a phase 2 trial, 72% of patients with high-grade clinical nonmuscle-invasive bladder cancer had a complete response at 3 months.
Researchers found elevated familial risks for testicular, prostate, bladder, and kidney cancers.
Risk factors include male gender, distant disease, increasing age, race/ethnicity
In a Canadian study, long wait times before a first urologist visit was associated with a 29% higher risk of death after radical cystectomy.
Smoking pot decreased the likelihood of the malignancy by 45%, whereas smoking tobacco only increased the likelihood by 52%.
Patients aged 70 and older are less likely than younger patients to receive post-cystectomy treatment, despite survival benefit
In community practice, overall rate of compliance with AUA Best Practices is less than 60 percent
Study of patients with muscle-invasive bladder cancer documents a particularly large increase in the use of neoadjuvant chemotherapy.
In a small randomized trial, functional and oncologic results did not differ significantly between the 2 approaches
These include patients with positive lymph nodes and surgical margins after cystectomy.
Transurethral resection of bladder tumor can cause cancer cells to be infused into the bloodstream.
Recurrence-free survival was 66 percent at five years for patients with bladder cancer who had laparoscopic radical cystectomy.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)